<< Read Full Article
<< Read Full Article
Updated from 11:45 a.m. EDT
Health care and biotech stocks followed the broader market's upward trend Thursday, thanks to merger and acquisition talk coming out of MedImmune (MEDI Quote).
Shares of the company jumped 15.3% after it indicated the possibility of a sale of the company. MedImmune's board has already authorized management to field potential offers. The stock added $5.79 to $43.63.
The Amex Biotechnology Index, of which MedImmune is a component, climbed 2.5%. Fellow components Imclone Systems (IMCL Quote) and Gilead Sciences (GILD Quote) rose 2.9% and 3%, respectively. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,302.74 | 1,090.10 | 2,131.77 | 32.07 |
Oil *
78.50
|
|
DOWN
7.18
|
DOWN
1.39
|
DOWN
6.67
|
DOWN
0.24
|
10 Yr
3.21%
SPDR Gold
115.42
|
|
-0.07%
|
-0.13%
|
-0.31%
|
-0.74%
|
Data delayed 20 minutes |
Connect with TheStreet